Cargando…
BioMOF-Based Anti-Cancer Drug Delivery Systems
A variety of nanomaterials have been developed specifically for biomedical applications, such as drug delivery in cancer treatment. These materials involve both synthetic and natural nanoparticles and nanofibers of varying dimensions. The efficacy of a drug delivery system (DDS) depends on its bioco...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005089/ https://www.ncbi.nlm.nih.gov/pubmed/36903831 http://dx.doi.org/10.3390/nano13050953 |
_version_ | 1784904994332344320 |
---|---|
author | Elmehrath, Sandy Nguyen, Ha L. Karam, Sherif M. Amin, Amr Greish, Yaser E. |
author_facet | Elmehrath, Sandy Nguyen, Ha L. Karam, Sherif M. Amin, Amr Greish, Yaser E. |
author_sort | Elmehrath, Sandy |
collection | PubMed |
description | A variety of nanomaterials have been developed specifically for biomedical applications, such as drug delivery in cancer treatment. These materials involve both synthetic and natural nanoparticles and nanofibers of varying dimensions. The efficacy of a drug delivery system (DDS) depends on its biocompatibility, intrinsic high surface area, high interconnected porosity, and chemical functionality. Recent advances in metal-organic framework (MOF) nanostructures have led to the achievement of these desirable features. MOFs consist of metal ions and organic linkers that are assembled in different geometries and can be produced in 0, 1, 2, or 3 dimensions. The defining features of MOFs are their outstanding surface area, interconnected porosity, and variable chemical functionality, which enable an endless range of modalities for loading drugs into their hierarchical structures. MOFs, coupled with biocompatibility requisites, are now regarded as highly successful DDSs for the treatment of diverse diseases. This review aims to present the development and applications of DDSs based on chemically-functionalized MOF nanostructures in the context of cancer treatment. A concise overview of the structure, synthesis, and mode of action of MOF-DDS is provided. |
format | Online Article Text |
id | pubmed-10005089 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100050892023-03-11 BioMOF-Based Anti-Cancer Drug Delivery Systems Elmehrath, Sandy Nguyen, Ha L. Karam, Sherif M. Amin, Amr Greish, Yaser E. Nanomaterials (Basel) Review A variety of nanomaterials have been developed specifically for biomedical applications, such as drug delivery in cancer treatment. These materials involve both synthetic and natural nanoparticles and nanofibers of varying dimensions. The efficacy of a drug delivery system (DDS) depends on its biocompatibility, intrinsic high surface area, high interconnected porosity, and chemical functionality. Recent advances in metal-organic framework (MOF) nanostructures have led to the achievement of these desirable features. MOFs consist of metal ions and organic linkers that are assembled in different geometries and can be produced in 0, 1, 2, or 3 dimensions. The defining features of MOFs are their outstanding surface area, interconnected porosity, and variable chemical functionality, which enable an endless range of modalities for loading drugs into their hierarchical structures. MOFs, coupled with biocompatibility requisites, are now regarded as highly successful DDSs for the treatment of diverse diseases. This review aims to present the development and applications of DDSs based on chemically-functionalized MOF nanostructures in the context of cancer treatment. A concise overview of the structure, synthesis, and mode of action of MOF-DDS is provided. MDPI 2023-03-06 /pmc/articles/PMC10005089/ /pubmed/36903831 http://dx.doi.org/10.3390/nano13050953 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Elmehrath, Sandy Nguyen, Ha L. Karam, Sherif M. Amin, Amr Greish, Yaser E. BioMOF-Based Anti-Cancer Drug Delivery Systems |
title | BioMOF-Based Anti-Cancer Drug Delivery Systems |
title_full | BioMOF-Based Anti-Cancer Drug Delivery Systems |
title_fullStr | BioMOF-Based Anti-Cancer Drug Delivery Systems |
title_full_unstemmed | BioMOF-Based Anti-Cancer Drug Delivery Systems |
title_short | BioMOF-Based Anti-Cancer Drug Delivery Systems |
title_sort | biomof-based anti-cancer drug delivery systems |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005089/ https://www.ncbi.nlm.nih.gov/pubmed/36903831 http://dx.doi.org/10.3390/nano13050953 |
work_keys_str_mv | AT elmehrathsandy biomofbasedanticancerdrugdeliverysystems AT nguyenhal biomofbasedanticancerdrugdeliverysystems AT karamsherifm biomofbasedanticancerdrugdeliverysystems AT aminamr biomofbasedanticancerdrugdeliverysystems AT greishyasere biomofbasedanticancerdrugdeliverysystems |